🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
To determine the safety and immunogenicity of Env 2-3 in combination with M...
Status
Completed
Location
Univ. of Rochester AVEG
Start Date
TBD
Trial ID
NCT00000958
Treatments Being Tested
The purpose of the study is to evaluate the safety, tolerability, and immun...
Status
Completed
Location
Brigham and Women's Hospital
Start Date
2021-07-08
Trial ID
NCT04927585
Treatments Being Tested
The purpose of this study is to evaluate the safety and immune response to ...
Status
Completed
Location
Polana Canico Health Research and Training Center (CISPOC), National Institute of Health (INS) CRS
Start Date
2017-06-19
Trial ID
NCT03284710
The objective of this experimental medicine study is to determine the exten...
Status
Completed
Location
NIHR Imperial Clinical Resarch Facility
Start Date
2019-03-19
Trial ID
NCT03816137
Treatments Being Tested
This study is designed to evaluate the safety and efficacy of lefitolimod a...
Status
Completed
Location
Dept. of Internal Medicine, University of Utah
Start Date
2019-05-06
Trial ID
NCT03837756
Treatments Being Tested
The humanised IgG4 monoclonal antibody GNbAC1 targets the envelope protein ...
Status
Terminated
Location
Hospital
Start Date
2017-06-06
Trial ID
NCT03239860
Treatments Being Tested
Background: HIV stands for human immunodeficiency virus, which is the viru...
Status
Completed
Location
National Institutes of Health Clinical Center
Start Date
2019-03-07
Trial ID
NCT03783130
Treatments Being Tested
The purpose of this study is to evaluate the safety and immunogenicity of H...
Status
Completed
Location
Alabama CRS
Start Date
2020-01-13
Trial ID
NCT04177355
The goal of this clinical trial is to test 16055 NFL delta Gly4 Env protein...
Status
Active Not Recruiting
Location
Alabama CRS
Start Date
2024-03-15
Trial ID
NCT06332339
Treatments Being Tested
This international, multi-centre, double-blind vaccine study is a three-arm...
Status
Completed
Location
MRC/UVRI and LSHTM Uganda Research Unit
Start Date
2020-12-15
Trial ID
NCT04066881
Treatments Being Tested